Interview with Jeff Williams

NeuMoDx™ Molecular was recently at ECCMID displaying our NeuMoDx™ Molecular 288 System. Our system is capable of automated extraction and isolation of nucleic acids from multiple specimen types, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR.

Listen to Jeff Williams, Chairman and CEO of NeuMoDx™ Molecular, explain why the NeuMoDx™ system is a game changer for automated PCR in the video below.